As of Jun 18
| -0.10 / -5.43%|
The 2 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a +158.62% increase from the last price of 1.74.
The current consensus among 4 polled investment analysts is to Buy stock in Infinity Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.